KURA ONCOLOGY, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.46 USD | +2.45% |
|
+11.52% | +35.95% |
| Apr. 22 | Sector Update: Health Care Stocks Advance Premarket Monday | MT |
| Apr. 22 | Kura Oncology Gets Breakthrough Designation For Leukemia Therapy | DJ |
Chart calendar Kura Oncology, Inc.
b891894cda4205fe8229b498fd3649fc.XzkhdjVcMef-GGVJ4x3m0YOkccVD3FYqM1t91yiVqSI.alF-Q3YxSZaIfCEclnjQhefmJIAumgxGcWkVgX_G3W4XcWQQZxd7gpJxUQ~7313683ac54f17f36e7c6926a241ffd2
Upcoming events on Kura Oncology, Inc.
Past events on Kura Oncology, Inc.
| 2024-04-17 11:30 am | Stifel Virtual Targeted Oncology Days Conference |
| 2024-03-14 09:00 am | Barclays Global Healthcare Conference |
| 2024-03-12 11:20 am | Leerink Partners Global Biopharma Conference |
| 2024-03-04 09:10 am | TD Cowen Health Care Conference |
| 2024-02-27 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-27 04:01 pm | Q4 2023 Earnings Release |
| 2024-01-30 08:00 am | Investor Meeting |
| 2023-12-05 02:00 pm | JMP Securities Hematology and Oncology Summit |
| 2023-11-16 05:30 am | Jefferies London Healthcare Conference |
| 2023-11-14 11:30 am | Stifel Healthcare Conference |
| 2023-11-03 12:00 pm | TD Cowen Fall Oncology Innovation Summit |
| 2023-11-02 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-02 04:01 pm | Q3 2023 Earnings Release |
| 2023-10-21 04:15 am | European Society for Medical Oncology Congress |
| 2023-10-13 12:30 pm | AACR-NCI-EORTC International Conference - Poster Number: B025 |
| 2023-10-13 12:30 pm | AACR-NCI-EORTC International Conference - Poster Number: B023 |
| 2023-10-13 12:30 pm | AACR-NCI-EORTC International Conference - Poster Number: B024 |
| 2023-09-26 11:05 am | Cantor Global Healthcare Conference |
| 2023-08-03 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-03 04:05 pm | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -67,5 -69,8 3.26% | -91,9 -91,8 -0.11% | -131 -139 6.01% | -139 -158 12.13% | -165 -162 -1.66% | -196 |
|
EBIT Million USD | Released Forecast Spread | -67,5 -68,3 1.15% | -91,9 -92,4 0.51% | -131 -136 3.72% | -140 -148 5.25% | -166 -163 -1.45% | -205 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -63,1 -64,3 1.82% | -89,6 -89,9 0.28% | -130 -135 3.16% | -136 -145 6.59% | -153 -153 0.17% | -197 |
|
Net income Million USD | Released Forecast Spread | -63,1 -64,3 1.82% | -89,6 -89,7 0.05% | -130 -134 2.78% | -136 -145 6.17% | -153 -153 0.04% | -194 |
|
EPS USD | Released Forecast Spread | -1,51 -1,53 1.38% | -1,69 -1,70 0.39% | -1,97 -2,02 2.66% | -2,03 -2,14 5.27% | -2,08 -2,08 0.04% | -2,32 |
| Announcement Date | 25/02/20 | 24/02/21 | 24/02/22 | 23/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -41,4 -41,1 -0.66% | -32,9 -34,1 3.6% | -32,6 -35,2 7.37% | -35,2 -34,7 -1.44% | -36,4 -35,9 -1.54% | -35,0 -53,0 34.08% | -36,4 -36,0 -1% | -39,8 -38,3 -3.89% | -42,3 -41,4 -2.07% | -46,5 -43,8 -6.27% | -47,0 | -50,5 | -51,3 | -53,4 | |
|
EBIT Million USD | Released Forecast Spread | -33,0 -38,1 13.32% | -32,8 -34,5 4.9% | -35,3 -35,0 -0.99% | -36,6 -37,9 3.34% | -35,2 -42,9 18.03% | -36,6 -37,5 2.53% | -40,0 -39,2 -1.98% | -42,5 -41,8 -1.53% | -46,8 -44,6 -4.76% | -47,8 | -50,2 | -52,3 | -54,9 | -48,4 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -32,7 -35,9 8.85% | -32,5 -34,2 5.21% | -34,8 -34,8 0.04% | -35,5 -37,7 5.92% | -33,1 -38,9 14.79% | -34,1 -36,6 7.02% | -37,2 -37,8 1.62% | -38,6 -40,4 4.56% | -42,8 -42,4 -0.9% | -46,1 | -48,0 | -49,9 | -52,9 | -48,0 | |
|
Net income Million USD | Released Forecast Spread | -32,7 -35,6 8.1% | -32,5 -34,4 5.58% | -34,8 -34,6 -0.4% | -35,5 -37,7 5.73% | -33,1 -38,7 14.54% | -34,1 -36,5 6.63% | -37,2 -37,9 1.95% | -38,6 -40,5 4.74% | -42,8 -42,6 -0.34% | -45,3 | -47,3 | -49,3 | -52,3 | -48,0 | |
|
EPS USD | Released Forecast Spread | -0,49 -0,54 8.53% | -0,49 -0,52 5.4% | -0,52 -0,52 -0.48% | -0,53 -0,56 5.99% | -0,49 -0,57 14.53% | -0,50 -0,54 7.92% | -0,53 -0,55 3.64% | -0,50 -0,55 8.95% | -0,55 -0,55 0.3% | -0,56 | -0,57 | -0,59 | -0,62 | -0,59 | |
| Announcement Date | 06/08/20 | 24/02/22 | 04/05/22 | 03/08/22 | 03/11/22 | 23/02/23 | 10/05/23 | 03/08/23 | 02/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Kura Oncology, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KURA Stock
- Calendar Kura Oncology, Inc.
